Huntington's disease drug: Teva Pharma settles patent dispute with Lupin, continues to litigate against Aurobindo Ruchika Sharma3 May 2022 4:05 PM ISTUnder the terms of the settlement agreement, Lupin will have a license to sell its generic product beginning April 2033, or earlier under certain...
Violation of drugs patents: Boehringer Ingelheim demands mechanisms in place Roshni Dhar26 April 2022 2:20 PM ISTDrug major Boehringer Ingelheim India has urged authorities to put in place a system that will inform patent holders whenever an application is filed...
Health Bulletin 23/April/2022 Roshni Dhar23 April 2022 5:34 PM ISTHere are the Top Health stories of the day:Foreign MBBS medicos must secure 50 percent marks in 10+2 to appear in FMGE: Delhi HCDismissing the plea by...
Violation of Drugs Patents: Boehringer Ingelheim demands authorities set mechanisms in place Ruchika Sharma21 April 2022 3:42 PM ISTA notification system would be helpful if any manufacturer files for approval with a state government and the DCGI and the patent holder is notified...
New study raises suspicion of coronavirus being developed in lab MD Bureau26 Feb 2022 12:19 PM ISTThe scientist team, including Akhil Varshney from Dr Shroff Charity Eye Hospital in New Delhi, showed a tiny snippet of a genetic material owned by...
Mylan, Apple lose US Supreme Court bids to challenge patent review rule Roshni Dhar24 Jan 2022 6:02 PM ISTThe U.S. Supreme Court on Tuesday turned back challenges by Apple Inc and drugmaker Mylan Laboratories Ltd to a rule change that made it harder to...
India demands patent waiver for COVID vaccines at World Trade Organization Ruchika Sharma27 Nov 2021 2:20 PM ISTNew Delhi: India will lead demands for an intellectual property rights waiver for COVID-19 vaccines and supplies at a World Trade Organization (WTO)...
Lupin to pay Rs 1824 crore to settle diabetes drug Glumetza suit in US Medical Dialogues Team23 Sept 2021 3:41 PM ISTNew Delhi: In an out-of-court settlement, Indian generic drug maker Lupin Pharmaceuticals Inc has decided to pay the Direct Purchaser Group Rs 1,103...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Aristo Pharma Medical Dialogues Team3 Sept 2021 6:24 PM ISTNew Delhi: Giving the benefits of patent expiry of popular antidiabetic drug, the National Pharmaceutical Pricing Authority (NPPA) panel has set the...
Delhi HC restrains Micro Lab from infringing Bristol Myers anticoagulant drug Apixaban Medical Dialogues Team19 Aug 2021 5:07 PM ISTNew Delhi: The Delhi High Court has passed an ex-parte ad- interim injunction restraining Micro Labs Limited from infringing any generic Apixaban...
Novartis moves court against Roche seeking Rs 1565 crore overpaid amount in patent licensing pact Medical Dialogues Team1 July 2021 5:23 PM ISTNew Delhi: Accusing Roche of illegally pocketing fee from a 16-year-old patent licensing contract, Novartis has filed a lawsuit in U.S. District Court...
Patent Infringement: MSD sues firm in Delhi HC over diabetes drug Sitagliptin Medical Dialogues Team20 Jun 2021 11:30 AM ISTNew Delhi: In a major victory for Merck Sharp and Dohme (MSD) Corp, the Delhi High Court has restrained Solitaire Pharmacia Private from infringing...
